High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

NCT06345495 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Splenomegaly
Myelofibrosis

Interventions

DRUG: Ruxolitinib
PROCEDURE: Allogeneic Stem Cell Transplantation
DRUG: Levetiracetam
DRUG: Eltrombopag
DRUG: Busulfan
DRUG: Romiplostim
DRUG: Fludarabine phosphate
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]